According to recent reports, Bayer has already paid out more than $1.6 billion in settlements over complications associated with its Yaz and Yasmin products, and the drug company continues to face thousands of lawsuits involving the potentially dangerous birth control pills. Bayer recently issued a third quarter report indicating that it has reached settlement agreements in about 7,660 Yaz and Yasmin cases involving blood clot injuries like pulmonary embolism and deep vein thrombosis (DVT). In addition, another 8,800 claimants have reportedly agreed to resolve claims over gallbladder injuries. If you took the oral contraceptives Yaz or Yasmin, and you have since suffered from a serious side effect like DVT or pulmonary embolism, contact a product liability lawyer in your area for legal help.
Even after resolving thousands of Yaz and Yasmin cases, there are still roughly 5,000 oral contraceptive claims pending against Bayer in courts throughout the country, over injuries linked to its Yaz, Yasmin, Ocella and Gianvi products. All of the cases involve similar allegations that Bayer failed to provide consumers with accurate warnings about the side effects of Yaz and Yasmin, as well as their generic equivalents – Ocella and Gianvi. The lawsuits allege that the fourth-generation progestin, drospirenone, which is found in all four birth control products, greatly increases a patient’s risk of blood clots when compared to older oral contraceptives.
Blood clots are extremely dangerous and can lead to life-threatening medical conditions like deep vein thrombosis, pulmonary embolism, heart attack, stroke and even gallbladder disease. While all birth control pills are known to carry an increased risk of blood clots, research has suggested that Yaz and Yasmin increase that risk considerably when compared to other oral contraceptives. Unfortunately, it wasn’t until a number of deaths were reported involving young, healthy women that this problems was finally brought to the attention of the public.
In the federal court system, the Yaz and Yasmin litigation has been consolidated for pretrial proceedings as part of a multidistrict litigation (MDL) in the Southern District of Illinois. According to Bayer, the drug company intends to continue considering settlement agreements in Yaz and Yasmin blood clot claims on a case-by-case basis, after reviewing claimants’ medical records. If you believe you have been adversely affected by a potentially dangerous pharmaceutical drug like Yaz or Yasmin, our consumer advocates at the Consumer Justice Foundation can help. We are dedicated to protecting the rights of consumers harmed by Big Pharma, and can put you in touch with a reputable attorney who has experience handling Yaz and Yasmin cases in your area.
[box type=”note” align=”aligncenter” ]Source: http://www.stockholders-newsletter-q3-2013.bayer.com/en/explanatory-notes.aspx#risks[/box]